Related Experiment Videos
[Fulminant pneumococcal sepsis in two splenectomized patients].
P A M de Vries1, A K L Oei-Reyners, A V M Möller
1Afd. Interne Geneeskunde, Intensive Care Beademing, Academisch Ziekenhuis, Postbus 30.001, 9700 RB Groningen.
Nederlands Tijdschrift Voor Geneeskunde
|April 2, 2003
Summary
Fulminant sepsis in splenectomized patients highlights the critical need for pneumococcal vaccination. Prompt medical attention for infection symptoms is vital, though vaccines offer incomplete protection against certain Streptococcus pneumoniae serotypes.
Area of Science:
- Infectious Diseases
- Immunology
- Critical Care Medicine
Background:
- Splenectomized individuals face increased risk of severe infections, particularly from encapsulated bacteria like Streptococcus pneumoniae.
- Fulminant sepsis is a life-threatening condition requiring intensive care management.
Observation:
- Two asplenic 41-year-old women presented with severe sepsis, characterized by petechiae, ecchymoses, renal insufficiency, and thrombocytopenia with disseminated intravascular coagulation.
- Blood cultures identified Streptococcus pneumoniae serotypes 24 and 38, which are not covered by the current polyvalent pneumococcal vaccine.
Findings:
- One patient succumbed to refractory septic shock, while the other, unvaccinated patient, survived the sepsis.
- The identified Streptococcus pneumoniae serotypes were outside the scope of the existing vaccine's protection.
Implications:
- This case series underscores the importance of pneumococcal vaccination in asplenic patients to mitigate sepsis risk.
- Patient education on recognizing and immediately reporting infection symptoms is crucial for timely intervention.
- Current vaccines do not offer complete protection against all Streptococcus pneumoniae serotypes, necessitating ongoing vigilance.